BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11394897)

  • 1. Morphological and physiological restorations of hereditary form of dilated cardiomyopathy by somatic gene therapy.
    Kawada T; Sakamoto A; Nakazawa M; Urabe M; Masuda F; Hemmi C; Wang Y; Shin WS; Nakatsuru Y; Sato H; Ozawa K; Toyo-oka T
    Biochem Biophys Res Commun; 2001 Jun; 284(2):431-5. PubMed ID: 11394897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters.
    Kawada T; Nakazawa M; Nakauchi S; Yamazaki K; Shimamoto R; Urabe M; Nakata J; Hemmi C; Masui F; Nakajima T; Suzuki J; Monahan J; Sato H; Masaki T; Ozawa K; Toyo-Oka T
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):901-6. PubMed ID: 11805334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors.
    Li J; Wang D; Qian S; Chen Z; Zhu T; Xiao X
    Gene Ther; 2003 Oct; 10(21):1807-13. PubMed ID: 12960970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy.
    Li J; Dressman D; Tsao YP; Sakamoto A; Hoffman EP; Xiao X
    Gene Ther; 1999 Jan; 6(1):74-82. PubMed ID: 10341878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Somatic gene therapy of dilated cardiomyopathy].
    Kawada T; Nakazawa M; Toyo-Oka T
    Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):37-44. PubMed ID: 11862755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy prevents disruption of dystrophin-related proteins in a model of hereditary dilated cardiomyopathy in hamsters.
    Toyo-oka T; Kawada T; Xi H; Nakazawa M; Masui F; Hemmi C; Nakata J; Tezuka A; Iwasawa K; Urabe M; Monahan J; Ozawa K
    Heart Lung Circ; 2002; 11(3):174-81. PubMed ID: 16352094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
    Rodino-Klapac LR; Lee JS; Mulligan RC; Clark KR; Mendell JR
    Neurology; 2008 Jul; 71(4):240-7. PubMed ID: 18525034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex.
    Sakamoto A; Ono K; Abe M; Jasmin G; Eki T; Murakami Y; Masaki T; Toyo-oka T; Hanaoka F
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13873-8. PubMed ID: 9391120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.
    Serose A; Prudhon B; Salmon A; Doyennette MA; Fiszman MY; Fromes Y
    Basic Res Cardiol; 2005 Mar; 100(2):161-70. PubMed ID: 15611844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain- and age-dependent loss of sarcoglycan complex in cardiomyopathic hamster hearts and its re-expression by delta-sarcoglycan gene transfer in vivo.
    Kawada T; Nakatsuru Y; Sakamoto A; Koizumi T; Shin WS; Okai-Matsuo Y; Suzuki J; Uehara Y; Nakazawa M; Sato H; Ishikawa T; Toyo-oka T
    FEBS Lett; 1999 Sep; 458(3):405-8. PubMed ID: 10570949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan.
    Shi W; Chen Z; Schottenfeld J; Stahl RC; Kunkel LM; Chan YM
    Muscle Nerve; 2004 Mar; 29(3):409-19. PubMed ID: 14981741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer.
    Zhu T; Zhou L; Mori S; Wang Z; McTiernan CF; Qiao C; Chen C; Wang DW; Li J; Xiao X
    Circulation; 2005 Oct; 112(17):2650-9. PubMed ID: 16230483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors.
    Goehringer C; Rutschow D; Bauer R; Schinkel S; Weichenhan D; Bekeredjian R; Straub V; Kleinschmidt JA; Katus HA; Müller OJ
    Cardiovasc Res; 2009 Jun; 82(3):404-10. PubMed ID: 19218289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel paradigm for therapeutic basis of advanced heart failure--assessment by gene therapy.
    Kawada T; Masui F; Kumagai H; Koshimizu M; Nakazawa M; Toyo-Oka T
    Pharmacol Ther; 2005 Jul; 107(1):31-43. PubMed ID: 15963350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
    Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defect of delta-sarcoglycan gene is responsible for development of dilated cardiomyopathy of a novel hamster strain, J2N-k: calcineurin/PP2B activity in the heart of J2N-k hamster.
    Mitsuhashi S; Saito N; Watano K; Igarashi K; Tagami S; Shima H; Kikuchi K
    J Biochem; 2003 Aug; 134(2):269-76. PubMed ID: 12966077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
    Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ
    Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
    Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
    Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.
    Badorff C; Lee GH; Lamphear BJ; Martone ME; Campbell KP; Rhoads RE; Knowlton KU
    Nat Med; 1999 Mar; 5(3):320-6. PubMed ID: 10086389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.
    Iwata Y; Katanosaka Y; Arai Y; Komamura K; Miyatake K; Shigekawa M
    J Cell Biol; 2003 Jun; 161(5):957-67. PubMed ID: 12796481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.